The Blued+ Combination HIV Prevention Pilot Study in China
Blued+
Integrating a Combination HIV Prevention Intervention Into a Widely-Used Geosocial App for Chinese MSM: Pilot Study
2 other identifiers
observational
423
1 country
1
Brief Summary
The proposed research includes a longitudinal pilot study to assess the feasibility and acceptability of Blued+. This combination HIV prevention intervention will integrate a combination package of HIV prevention services into Blued, a gay dating App, for men who have sex with men (MSM) in China. Despite high HIV incidence among MSM, HIV prevention interventions such as pre-exposure prophylaxis (PrEP) use remains low in China. If the HIV prevention intervention services provided through the Blued+ App prove feasible and acceptable, the pilot test will facilitate the design of a larger study of intervention efficacy. The study population will be self-reported HIV-negative Blued users who are 18 years of age or greater, were assigned a male sex at birth, report having anal sex with a man in the last 6 months, eligible for PrEP according to China's consensus statement, and reside in metropolitan Beijing or Chengdu, China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedFirst Submitted
Initial submission to the registry
October 16, 2024
CompletedFirst Posted
Study publicly available on registry
October 17, 2024
CompletedResults Posted
Study results publicly available
July 16, 2025
CompletedJuly 16, 2025
June 1, 2025
1.4 years
October 16, 2024
June 6, 2025
June 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of Blued+ in China
The intervention will be determined to be feasible if a minimum proportion of participants receive services for home HIV testing (benchmark ≥30%) and PrEP initiation (benchmark ≥20%) through Blued+
12 months after intervention initiation, 15 months after first study interaction
System Usability Scale (SUS)
Acceptability of Blued+ in China will be measured using the System Usability Scale (SUS). The SUS is a widely used scale that evaluates the usability of products and systems through a 10-item question set. The total range of a score on this scale is 0 to 100. This scale does not have any sub-scales. Higher scores on this scale represent higher levels of intervention usability, with 100 being the highest usability and 0 being the lowest usability. Information on this scale and how to calculate values is found in: Bangor, Aaron, Philip T. Kortum, and James T. Miller. "An empirical evaluation of the system usability scale." Intl. Journal of Human-Computer Interaction 24.6 (2008): 574-594. The intervention will be considered acceptable if it reaches a total SUS rating score of ≥ 71/100, which has been interpreted as being 'good' usability.
12 months after intervention initiation, 15 months after first study interaction
Study Arms (1)
Blued App
A three-month run-in period with the standard of care followed by the Blued+ intervention with participants for 12 months.
Interventions
During the intervention period, participants received the enhanced version of the Blued app. The free HIV prevention services were integrated into the Blued app: health messaging, in-home HIV testing, linkage to care for those testing HIV positive, condoms, lubricants, in-app screening, and provision to PrEP.
Eligibility Criteria
The study population includes registered Blued users who self-report male sex at birth, are age 18 years or older, who report anal sex with a man in the past 6 months, behaviorally eligible for PrEP, and who do not report an HIV diagnosis. Eligible men will be residents of metropolitan areas of Beijing or Chengdu, China.
You may qualify if:
- Registered Blued app user
- ≥18 years of age
- Male sex at birth
- Self-report anal sex with a man in the last 6 months
- HIV-negative or unknown HIV status
- Behaviorally eligible for PrEP per published China guidance
- Able to complete study instruments in Mandarin Chinese
- Resident of the metropolitan area of Beijing or Chengdu, China
- Eligible for PrEP based on China's consensus statement
You may not qualify if:
- Not a registered Blued app user
- \<18 years of age
- Not male sex at birth
- Does not report anal sex with a man in the last 6 months
- Has previously tested positive for HIV
- Not eligible for PrEP per published China guidance
- Unable to complete study instruments in Mandarin Chinese
- Not a resident of the metropolitan area of Beijing or Chengdu, China
- Currently enrolled in another HIV prevention study
- Evidence of fraudulent participation, such as a duplicate IP address, multiple screening attempts, duplicate emails, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute of Allergy and Infectious Diseases (NIAID)collaborator
- BlueD Chinacollaborator
Study Sites (1)
BlueD
Beijing, China
Related Publications (1)
Huang W, Ning K, Koh SHE, Mi G, Yu F, Liu Y, Stegmueller D, Powers KA, Baral S, Sullivan PS, Siegler AJ. Integrating a Combination HIV Prevention Intervention Into a Widely Used Geosocial App for Chinese Men Who Have Sex With Men: Protocol for a Single-Arm Pilot and Repeated Cross-Sectional Study. JMIR Res Protoc. 2025 Sep 29;14:e69536. doi: 10.2196/69536.
PMID: 41021915DERIVED
Limitations and Caveats
This was a pilot study with a single arm.
Results Point of Contact
- Title
- Dr. Aaron Siegler
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Aaron Siegler, PhD
Emory University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 16, 2024
First Posted
October 17, 2024
Study Start
July 15, 2022
Primary Completion
December 12, 2023
Study Completion
February 28, 2024
Last Updated
July 16, 2025
Results First Posted
July 16, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share